|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$84,919,510 |
|
|
Indirect Value
|
$13,116,072,593 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,200,992,103 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
![](../../../Gifs/iconPlus.jpg) |
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
![](../../../Gifs/iconPlus.jpg) |
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 41 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2006-06-09 |
4 |
B |
$4.00 |
$124,916 |
I/I |
31,197 |
68,988 |
2.1 |
- |
|
ALTH |
Allos Therapeutics Inc |
10% Owner |
|
2008-01-10 |
4 |
B |
$7.47 |
$235,564 |
I/I |
31,538 |
2,381,777 |
1.5 |
- |
|
ADLR |
Adolor Corp |
10% Owner |
|
2010-10-29 |
4 |
S |
$1.18 |
$37,461 |
I/I |
(31,666) |
6,666,436 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2008-06-27 |
4 |
S |
$15.41 |
$489,899 |
I/I |
(31,791) |
57,667 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-15 |
4 |
B |
$28.88 |
$927,680 |
I/I |
32,125 |
7,407,547 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-27 |
4 |
B |
$4.03 |
$130,374 |
I/I |
32,297 |
1,295,373 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-30 |
4 |
S |
$12.03 |
$388,909 |
I/I |
(32,332) |
1,330,050 |
0 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2010-05-06 |
4 |
S |
$12.62 |
$410,982 |
I/I |
(32,508) |
312,441 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$410,220 |
I/I |
32,630 |
1,215,554 |
2.25 |
- |
|
VPHM |
Viropharma Inc |
10% Owner |
|
2011-09-29 |
4 |
B |
$17.97 |
$593,488 |
I/I |
32,995 |
1,876,525 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2003-10-06 |
4 |
B |
$10.80 |
$356,940 |
I/I |
33,050 |
39,732 |
1.5 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2012-02-08 |
4 |
B |
$26.17 |
$868,267 |
I/I |
33,141 |
1,339,422 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2009-03-02 |
4/A |
B |
$2.14 |
$71,831 |
I/I |
33,364 |
7,060,749 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2009-03-02 |
4 |
B |
$2.14 |
$71,831 |
I/I |
33,364 |
7,060,749 |
2.25 |
- |
|
TPPHQ |
Tapestry Pharmaceuticals ... |
10% Owner |
|
2008-05-28 |
4 |
D |
$0.00 |
$0 |
I/I |
(34,035) |
7,085 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-26 |
4 |
B |
$4.00 |
$136,919 |
I/I |
34,216 |
1,263,076 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-29 |
4 |
B |
$16.39 |
$561,850 |
I/I |
34,288 |
1,145,120 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2010-08-10 |
4 |
S |
$14.00 |
$482,421 |
I/I |
(34,462) |
3,330,071 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2010-09-01 |
4 |
B |
$14.43 |
$499,331 |
I/I |
34,578 |
4,925,760 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-10-29 |
4 |
S |
$12.47 |
$431,430 |
I/I |
(34,606) |
1,362,382 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2008-01-14 |
4 |
B |
$10.99 |
$380,398 |
I/I |
34,621 |
5,427,653 |
2.25 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2005-07-14 |
4 |
B |
$3.50 |
$121,247 |
I/I |
34,642 |
35,898 |
1.5 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-08-11 |
4 |
B |
$4.03 |
$139,991 |
I/I |
34,745 |
1,523,919 |
2.25 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-09-10 |
4 |
B |
$12.55 |
$439,185 |
I/I |
34,934 |
1,691,130 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-02-25 |
4 |
B |
$23.89 |
$843,196 |
I/I |
35,078 |
5,093,345 |
2.25 |
- |
|
1397 Records found
|
|
Page 41 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|